Article

• Select this article
  • Matthew J Schiewer,
  • Robert Den,
  • David T Hoang,
  • Michael A Augello,
  • Yaacov R Lawrence,
  • Adam P Dicker,
  • and Karen E Knudsen

  mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer

  Endocr Relat Cancer 19 (1) 1-12, doi:10.1530/ERC-11-0072 first published on 8 September 2011
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
  • Supplementary Data

  OPEN ACCESS ARTICLE
• Select this article
  • B Shan,
  • J Gerez,
  • M Haedo,
  • M Fuertes,
  • M Theodoropoulou,
  • M Buchfelder,
  • M Losa,
  • G K Stalla,
  • E Arzt,
  • and U Renner

  RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells

  Endocr Relat Cancer 19 (1) 13-27, doi:10.1530/ERC-11-0211 first published on 18 October 2011
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Yoon Woo Koh,
  • Manisha H Shah,
  • Kitty Agarwal,
  • Samantha K McCarty,
  • Bon Seok Koo,
  • Victoria J Brendel,
  • Chaojie Wang,
  • Kyle Porter,
  • David Jarjoura,
  • Motoyasu Saji,
  • and Matthew D Ringel

  Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro

  Endocr Relat Cancer 19 (1) 29-38, doi:10.1530/ERC-11-0155 first published on 22 November 2011
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Sonia D'Inzeo,
  • Arianna Nicolussi,
  • Caterina Francesca Donini,
  • Massimo Zani,
  • Patrizia Mancini,
  • Francesco Nardi,
  • and Anna Coppa

  A novel human Smad4 mutation is involved in papillary thyroid carcinoma progression

  Endocr Relat Cancer 19 (1) 39-55, doi:10.1530/ERC-11-0233 first published on 22 November 2011
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
  • Supplementary Data
• Select this article
  • Leticia M Nogueira,
  • Sarah M Dunlap,
  • Nikki A Ford,
  • and Stephen D Hursting

  Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity

  Endocr Relat Cancer 19 (1) 57-68, doi:10.1530/ERC-11-0213 first published on 5 December 2011
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
  • Supplementary Data
• Select this article
  • Jonathan G Bijron,
  • Petra van der Groep,
  • Eleonora B van Dorst,
  • Laura M S Seeber,
  • Daisy M D S Sie-Go,
  • René H M Verheijen,
  • and Paul J van Diest

  Promoter hypermethylation patterns in fallopian tube epithelium of BRCA1 and BRCA2 germ line mutation carriers

  Endocr Relat Cancer 19 (1) 69-81, doi:10.1530/ERC-11-0338 first published on 5 December 2011
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Jay S Fonte,
  • Jeremyjones F Robles,
  • Clara C Chen,
  • James Reynolds,
  • Millie Whatley,
  • Alexander Ling,
  • Leilani B Mercado-Asis,
  • Karen T Adams,
  • Victoria Martucci,
  • Tito Fojo,
  • and Karel Pacak

  False-negative ¹²³I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease

  Endocr Relat Cancer 19 (1) 83-93, doi:10.1530/ERC-11-0243 first published on 13 December 2011
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Kimberly Kamp,
  • Ronald A M Damhuis,
  • Richard A Feelders,
  • and Wouter W de Herder

  Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreas

  Endocr Relat Cancer 19 (1) 95-99, doi:10.1530/ERC-11-0315 first published on 22 December 2011
  • Abstract
  • Full Text
  • Full Text (PDF)
• Select this article
  • Alberto Ferlin,
  • Manuel Pengo,
  • Damiano Pizzol,
  • Umberto Carraro,
  • Anna Chiara Frigo,
  • and Carlo Foresta

  Variants in KITLG predispose to testicular germ cell cancer independently from spermatogenic function

  Endocr Relat Cancer 19 (1) 101-108, doi:10.1530/ERC-11-0340 first published on 22 December 2011
  • Abstract
  • Full Text
  • Full Text (PDF)